Study Indicates Take-at-Home, Oral Ketamine is an Effective Option for Treatment-Resistant Depression

The daily oral formulation of ketamine, KET01, has the potential to greatly improve the standard treatment practices for treatment-resistant depression, according to investigators.

Related Keywords

Czech Republic ,Poland ,Germany ,Develco Pharma ,Hans Eriksson ,Martin Walter ,Psychotherapy Of University Jena ,Department Of Psychiatry ,Brain Health ,University Jena ,Clinician Administered Dissociative States Scale ,Top Line Results From Phase ,Oral Ketamine Option ,Ketamine Demonstrated ,Blind Trial Shows Low Cost Subcutaneous Version ,Effective Over Placebo ,Treating Treatment Resistant ,